EPTIFIBATIDE INJECTION DIN 02405083
Health Canada record
| Active ingredient(s) | EPTIFIBATIDE 0.75 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AC16 EPTIFIBATIDE |
| Original market date | 29-Apr-2013 |
| Current status date | 30-Apr-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPTIFIBATIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02540827 | EPTIFIBATIDE INJECTION | JUNO PHARMA CANADA INC. | Solution | EPTIFIBATIDE 2 MG | Marketed |
| 02422840 | EPTIFIBATIDE INJECTION | STRIDES PHARMA CANADA INC | Solution | EPTIFIBATIDE 0.75 MG | Approved |
| 02422859 | EPTIFIBATIDE INJECTION | STRIDES PHARMA CANADA INC | Solution | EPTIFIBATIDE 2 MG | Approved |
| 02540819 | EPTIFIBATIDE INJECTION | JUNO PHARMA CANADA INC. | Solution | EPTIFIBATIDE 0.75 MG | Marketed |
| 02410109 | EPTIFIBATIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | EPTIFIBATIDE 0.75 MG | Cancelled Pre Market |
| 02460386 | EPTIFIBATIDE INJECTION | FRESENIUS KABI CANADA LTD | Solution | EPTIFIBATIDE 2 MG | Cancelled Pre Market |
| 02367858 | EPTIFIBATIDE INJECTION | TEVA CANADA LIMITED | Solution | EPTIFIBATIDE 2 MG | Cancelled Post Market |
| 02410125 | EPTIFIBATIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | EPTIFIBATIDE 2 MG | Cancelled Pre Market |
| 02454483 | EPTIFIBATIDE INJECTION | ACCORD HEALTHCARE INC | Solution | EPTIFIBATIDE 0.75 MG | Cancelled Pre Market |
| 02454491 | EPTIFIBATIDE INJECTION | ACCORD HEALTHCARE INC | Solution | EPTIFIBATIDE 2 MG | Cancelled Pre Market |
| 02460378 | EPTIFIBATIDE INJECTION | FRESENIUS KABI CANADA LTD | Solution | EPTIFIBATIDE 0.75 MG | Cancelled Pre Market |
| 02240351 | INTEGRILIN | MERCK CANADA INC | Solution | EPTIFIBATIDE 0.75 MG | Cancelled Post Market |
| 02240352 | INTEGRILIN | MERCK CANADA INC | Solution | EPTIFIBATIDE 2 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14319 | 2013-04-29 | Supplement to an Abbreviated New Drug Submission (SANDS) | New strength |
International API supply for EPTIFIBATIDE
12 active FDA Drug Master Files.
Request a quote for EPTIFIBATIDE INJECTION